Facilitating DCT with DtP Trial Strategy

Facilitating DCT with DtP Trial Strategy
June 13, 2022 YPrime

A direct-to-patient (DtP) clinical trial design, where investigational medicinal products (IMP) and clinical supplies are shipped or delivered directly to patients, fits within a decentralized clinical trial (DCT) model. Although patients, sites, and sponsors can all benefit from this trial design, there are unique complexities to DtP trials, that can be managed with advanced technology. In this podcast, Jon Paras talks about this trial strategy, the unique challenges, what the industry is doing to address these challenges and how technology can help facilitate adoption of this trial design.

Listen to the podcast to learn more about why a sponsor would want to adopt a direct-to-patient clinical trial strategy and the benefit to patients.

PODCAST

Facilitating DCT with DtP Trial Strategy

Jon Paras

RELATED CONTENT

Understanding Decentralized Clinical Trials

Understanding Decentralized Clinical Trials

Effective Use of IRT in Decentralized and Hybrid Clinical Trials

Effective Use of IRT in Decentralized and Hybrid Clinical Trials

The Importance of IRT in the Decentralized Clinical Trial Landscape

The Importance of IRT in the Decentralized Clinical Trial Landscape

LATEST CONTENT

Why and How Will eCommerce Transform the IRT User Experience?

Why and How Will eCommerce Transform the IRT User Experience?

eCOA Rescue and Rapid Deployment for a Phase 3 Respiratory Study

eCOA Rescue and Rapid Deployment for a Phase 3 Respiratory Study

Electronic Clinical Outcome Assessment (eCOA) For Clinical Studies

Electronic Clinical Outcome Assessment (eCOA) For Clinical Studies